全文获取类型
收费全文 | 1233篇 |
免费 | 62篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 52篇 |
妇产科学 | 14篇 |
基础医学 | 150篇 |
口腔科学 | 28篇 |
临床医学 | 158篇 |
内科学 | 301篇 |
皮肤病学 | 28篇 |
神经病学 | 39篇 |
特种医学 | 146篇 |
外科学 | 193篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 74篇 |
眼科学 | 4篇 |
药学 | 93篇 |
中国医学 | 4篇 |
肿瘤学 | 48篇 |
出版年
2021年 | 11篇 |
2020年 | 6篇 |
2019年 | 9篇 |
2018年 | 16篇 |
2017年 | 6篇 |
2016年 | 17篇 |
2015年 | 13篇 |
2014年 | 15篇 |
2013年 | 24篇 |
2012年 | 53篇 |
2011年 | 46篇 |
2010年 | 26篇 |
2009年 | 29篇 |
2008年 | 39篇 |
2007年 | 79篇 |
2006年 | 52篇 |
2005年 | 45篇 |
2004年 | 53篇 |
2003年 | 34篇 |
2002年 | 59篇 |
2001年 | 45篇 |
2000年 | 45篇 |
1999年 | 51篇 |
1998年 | 39篇 |
1997年 | 31篇 |
1996年 | 37篇 |
1995年 | 29篇 |
1994年 | 28篇 |
1993年 | 17篇 |
1992年 | 21篇 |
1991年 | 29篇 |
1990年 | 34篇 |
1989年 | 40篇 |
1988年 | 34篇 |
1987年 | 27篇 |
1986年 | 23篇 |
1985年 | 28篇 |
1984年 | 11篇 |
1983年 | 14篇 |
1982年 | 9篇 |
1981年 | 14篇 |
1980年 | 10篇 |
1979年 | 8篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1976年 | 8篇 |
1975年 | 14篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1972年 | 7篇 |
排序方式: 共有1364条查询结果,搜索用时 15 毫秒
1.
R. H. Wiesner B. J. Steffen K. M. David A. H. Chu R. D. Gordon J. R. Lake 《American journal of transplantation》2006,6(7):1609-1616
Mycophenolate mofetil (MMF) used in a triple-drug regimen has been shown to decrease acute rejection rates, compared to a double-drug regimen. The impact of MMF on late acute rejection (LAR) episodes has not been well described. To investigate the risk of LAR (rejection > or = 6 months post-transplantation) data from the Scientific Registry of Transplant Recipients (SRTR) were used. We studied adult primary liver transplant recipients transplanted between June 1, 1995, and April 30, 2004, with hepatitis C virus (HCV) (n = 3356), hepatitis B virus (HBV) (n = 550) or a nonviral (n = 5740) primary cause of liver disease who were recorded as receiving continuous 3-(MMF + Tacro + steroids) versus 2-drug (Tacro + steroids) therapy for at least 6 months immediately post transplantation. Kaplan-Meier analysis showed significantly lower LAR rates 4 years post-transplant in 3- versus 2-drug HCV, HBV and nonviral disease patients. Multivariate regression confirmed 3- versus 2-drug therapy to be associated with a decreased risk of LAR. Late graft survival was significantly lower at 4 years post-transplant for patients with LAR 6-12 months post-transplantation versus patients with early rejection (78.0% vs. 87.0%, p < 0.001) and no rejection (88.1%, p < 0.001). Three-drug versus 2-drug therapy for a minimum of 6 months may offer a better treatment strategy to avoid the consequences and expense of LAR episodes. 相似文献
2.
3.
4.
5.
The advantages of the new, safer, but more expensive iodinated contrast agents are discussed, and opinions on which patient groups should receive the agents are presented. 相似文献
6.
7.
8.
C V Paya R H Wiesner P E Hermans J J Larson-Keller D M Ilstrup R A Krom S B Moore J Ludwig T F Smith 《Hepatology (Baltimore, Md.)》1992,16(1):66-70
In this study we evaluated the association between cytomegalovirus infection alone or in relation to human leukocyte antigen matching and the development of vanishing bile duct syndrome, a form of chronic hepatic allograft rejection. A total of 81 consecutive liver transplant recipients were studied. Cytomegalovirus infection developed in 46 recipients (57%), and vanishing bile duct syndrome occurred in 9 recipients (11%). Cytomegalovirus infection developed in only five of the nine patients with vanishing bile duct syndrome. Univariate analysis of pretransplant recipient/donor cytomegalovirus serological tests and human leukocyte antigen typing showed they were not significant risk factors for the development of vanishing bile duct syndrome. Time-dependent analysis of cytomegalovirus infection after transplantation as a risk factor for vanishing bile duct syndrome, in a multivariate analysis with human leukocyte antigen match, showed no statistical significance. In our study, no association was found between cytomegalovirus infection alone or in relation to class I or II human leukocyte antigen match and the subsequent development of vanishing bile duct syndrome. 相似文献
9.
L. Wiesner S. Krupp E. Holzer M. Boumghar G. Chapuis N. Genton 《European journal of plastic surgery》1993,16(3):118-121
Summary From 1981 to. 1989, a total of 13 procedures were performed on 12 patients requiring complex reconstructions of the thoracic wall. The most common cause of these defects was cancer. Muscle flaps remain the treatment of choice for thoracic wall reconstruction and have been used in 10 cases. Microsurgical tissue transfer opens even larger therapeutic perspectives. A team approach is recommended. 相似文献
10.
Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Annals of surgery》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A H Kartheuser R R Dozois R H Wiesner N F LaRusso D M Ilstrup C D Schleck 《Annals of surgery》1993,217(4):314-320
OBJECTIVE: This study determined predictive factors for postoperative complications and outcome after ileal pouch-anal anastomosis in patients with ulcerative colitis and primary sclerosing cholangitis. SUMMARY BACKGROUND DATA: Patients with ulcerative colitis and primary sclerosing cholangitis treated by colectomy and ileostomy are at high risk of troublesome bleeding from peristomal varices. METHODS: Postoperative complications and outcome were assessed in 40 patients with ulcerative colitis and sclerosing cholangitis who received an ileal pouch-anal anastomosis between January 1981 and February 1990. RESULTS: Immediate postoperative and remote ileoanal anastomosis-related complications were high but related directly to the severity of liver disease. No patient had perianastomotic anal bleeding. CONCLUSIONS: In patients with both ulcerative colitis and primary sclerosing cholangitis, ileal pouch-anal anastomosis is safe and is not associated with perianastomotic bleeding. 相似文献